Get access

Reopening the case for anti–basal ganglia antibodies (ABGAs): Identification of dopamine-2 receptor antibodies associated with movement disorders

Authors


  • Financial Disclosures: Bettina Balint has nothing to disclose. Kailash Bhatia: advisor/honoraria/financial support to speak/attend meetings from GSK, Boehringer-Ingelheim, Ipsen, Merz, and Orion pharma companies. Grants by the Dystonia Society UK and the Halley Stewart Trust.

No abstract is available for this article.

Get access to the full text of this article

Ancillary